Extensively Drug-Resistant Tuberculosis and HIV/AIDS

AIDS and Tuberculosis: A Deadly Liaison

Volumn , Issue , 2009, Pages 253-275

  Murray, Megan ^a,b   Cohen, Ted ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adherence; Extensive drug resistance; Fitness costs; HIV; Multidrug resistance; Second line drugs; Tuberculosis

Indexed keywords

EID: 84861462511     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527627905.ch10     Document Type: Chapter

References (110)

1. Gandhi, N.R., Moll, A., Sturm, A.W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J. and Friedland, G. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 368, 1575-1580.
2. Andrews, J.R., Shah, N.S., Gandhi, N., Moll, T. and Friedland, G. (2007) Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J. Infect. Dis., 196 (Suppl. 3), S482-S490.
3. Shah, N.S., Pratt, R., Armstrong, L., Robison, V., Castro, K.G. and Cegielski, J.P. (2008) Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA, 300, 2153-2160.
4. Van Rie, A. and Enarson, D. (2006) XDR tuberculosis: an indicator of public-health negligence. Lancet, 368, 1554-1556.
5. Coronado, V.G., Beck-Sague, C.M., Hutton, M.D., Davis, B.J., Nicholas, P., Villareal, C.,Woodley, C.L., Kilburn, J.O., Crawford, J.T. and Frieden, T.R. et al. (1993) Transmission of multidrugresistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J. Infect. Dis., 168, 1052-1055.
6. Edlin, B.R., Tokars, J.I., Grieco, M.H., Crawford, J.T., Williams, J., Sordillo, E.M., Ong, K.R., Kilburn, J.O., Dooley, S.W. and Castro, K.G. et al. (1992) An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N. Engl. J. Med., 326, 1514-1521.
7. Friedman, C.R., Stoeckle, M.Y., Kreiswirth, B.N., Johnson, W.D. Jr, Manoach, S.M., Berger, J., Sathianathan, K., Hafner, A. and Riley, L.W. (1995) Transmission of multidrug-resistant tuberculosis in a large urban setting. Am. J. Respir. Crit. Care Med., 152, 355-359.
8. Moss, A.R., Alland, D., Telzak, E., Hewlett, D. Jr, Sharp, V., Chiliade, P., LaBombardi, V., Kabus, D., Hanna, B., Palumbo, L., Brudney, K., Weltman, A., Stoeckle, K., Chirgwin, K., Simberkoff, M., Moghazeh, S., Eisner, W., Lutfey, M. and Kreiswirth, B. (1997) A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int. J. Tuberc. Lung Dis., 1, 115-121.
9. Schaffer, R. (1954) The rehabilitation of the general practitioner. S. Afr.Med. J., 28, 647-649.
10. Valway, S.E., Richards, S.B., Kovacovich, J., Greifinger, R.B., Crawford, J.T. and Dooley, S.W. (1994) Outbreak of multidrug-resistant tuberculosis in a New York State prison, 1991. Am. J. Epidemiol., 140, 113-122.
11. Paolo,W.F. Jr, and Nosanchuk, J.D. (2004) Tuberculosis in New York city: recent lessons and a look ahead. Lancet Infect. Dis., 4, 287-293.
12. World Health Organization (2008) Countries with XDR-TB confirmed cases as of June 2008, WHO Geneva, Switzerland.
13. Ben Amor, Y., Nemser, B., Singh, A., Sankin, A. and Schluger, N. (2008) Underreported threat of multidrugresistant tuberculosis in Africa. Emerg. Infect. Dis., 14, 1345-1352.
14. Demissie, M., Lemma, E., Gebeyehu, M. and Lindtjorn, B. (2001) Sensitivity to anti-tuberculosis drugs in HIV-positive and -negative patients in Addis Ababa. Scand. J. Infect. Dis., 33, 914-919.
15. Mac-Arthur, A., Gloyd, S., Perdigao, P., Noya, A., Sacarlal, J. and Kreiss, J. (2001) Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int. J. Tuberc. Lung Dis., 5, 894-902.
16. Small, P.M., Shafer, R.W., Hopewell, P.C., Singh, S.P., Murphy, M.J., Desmond, E., Sierra, M.F. and Schoolnik, G.K. (1993) Exogenous reinfection with multidrugresistant Mycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med., 328, 1137-1144.
17. Wells, C.D., Cegielski, J.P., Nelson, L.J., Laserson, K.F., Holtz, T.H., Finlay, A., Castro, K.G. and Weyer, K. (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J. Infect. Dis., 196 (Suppl. 1), S86-S107.
18. Weyer, K., Van der Walt, M., Brand, J., Lancaster, J. and Levin, J.B. (2003) Survey of Tuberculosis drug resistance in South Africa: final report. Medical Research Council, Pretoria.
19. Chum, H.J., O'Brien, R.J., Chonde, T.M., Graf, P. and Rieder, H.L. (1996) An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS, 10, 299-309.
20. Churchyard, G.J., Corbett, E.L., Kleinschmidt, I.,Mulder,D. and De Cock, K.M. (2000) Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int. J. Tuberc. Lung Dis., 4, 433-440.
21. Espinal, M.A., Laserson, K.,Camacho, M., Fusheng, Z., Kim, S.J., Tlali, R.E., Smith, I., Suarez, P., Antunes, M.L., George, A.G., Martin-Casabona, N., Simelane, P., Weyer, K., Binkin, N. and Raviglione, M.C. (2001) Determinants of drugresistant tuberculosis: analysis of 11 countries. Int. J. Tuberc. Lung Dis., 5, 887-893.
22. Kenyon, T.A., Mwasekaga, M.J.,Huebner, R., Rumisha, D., Binkin, N. andMaganu, E. (1999) Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int. J. Tuberc. Lung Dis., 3, 4-11.
23. Nunes, E.A., De Capitani, E.M., Coelho, E., Joaquim, O.A., Figueiredo, I.R., Cossa, A.M., Panunto, A.C. and Carvalho-Ramos, M. (2005) Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique 2002-2003. Int. J. Tuberc. Lung Dis., 9, 494-500.
24. Pereira, M., Tripathy, S., Inamdar, V., Ramesh, K., Bhavsar, M., Date, A., Iyyer, R., Acchammachary, A., Mehendale, S. and Risbud, A. (2005) Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J. Med. Res., 121, 235-239.
25. Quy, H.T., Buu, T.N., Cobelens, F.G., Lan, N.T., Lambregts, C.S. and Borgdorff, M.W. (2006) Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int. J. Tuberc. Lung Dis., 10, 160-166.
26. Warndorff, D.K., Yates, M., Ngwira, B., Chagaluka, S., Jenkins, P.A., Drobniewski, F., Ponnighaus, J.M., Glynn, J.R. and Fine, P.E. (2000) Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int. J. Tuberc. Lung Dis., 4, 752-757.
27. World Health Organization (2008) Anti-Tuberculosis Drug Resistant in the World Report No. 4. World Health Organization, Geneva.
28. Vilarica, A.S., Gomes, C. and Pina, J. (2008) Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis -Epidemiology and predictive factors. Rev. Port. Pneumol., 14, 829-842.
29. van Rie, A., Warren, R., Richardson, M., Victor, T.C., Gie, R.P., Enarson, D.A., Beyers, N. and van Helden, P.D. (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med., 341, 1174-1179.
30. Dye, C., Williams, B.G., Espinal, M.A. and Raviglione, M.C. (2002) Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science, 295, 2042-2046.
31. Kaona, F.A., Tuba, M., Siziya, S. and Sikaona, L. (2004) An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health, 4, 68.
32. Marco, A.,Cayla, J.A., Serra, M., Pedro, R., Sanrama, C., Guerrero, R. and Ribot, N. (1998) Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur. Respir. J., 12, 967-971.
33. Munro, S.A., Lewin, S.A., Smith, H.J., Engel, M.E., Fretheim, A. and Volmink, J. (2007) Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med., 4, e238.
34. Connolly, C., Davies, G.R. and Wilkinson, D. (1999) Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa. Int. J. Tuberc. Lung Dis., 3, 1081-1087.
35. Pablos-Mendez, A., Knirsch, C.A., Barr, R.G., Lerner, B.H. and Frieden, T.R. (1997) Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am. J. Med., 102, 164-170.
36. Fry, R.S., Khoshnood, K., Vdovichenko, E., Granskaya, J., Sazhin, V., Shpakovskaya, L., Zhemkov, V., Zhemkova, M., Rowhani-Rahbar, A., Funk, M. and Kozlov, A. (2005) Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. Int. J. Tuberc. Lung Dis., 9, 1027-1033.
37. Garner, P., Smith, H., Munro, S. and Volmink, J. (2007) Promoting adherence to tuberculosis treatment. Bull. World Health Org., 85, 404-406.
38. Schaberg, T., Rebhan, K. and Lode, H. (1996) Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur. Respir. J., 9, 2026-2030.
39. Tekle, B.,Mariam, D.H. and Ali, A. (2002) Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int. J. Tuberc. Lung Dis., 6, 573-579.
40. Choudhri, S.H., Hawken, M., Gathua, S., Minyiri, G.O., Watkins, W., Sahai, J., Sitar, D.S., Aoki, F.Y. and Long, R. (1997) Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea. Clin. Infect. Dis., 25, 104-111.
41. Alland, D., Kalkut, G.E., Moss, A.R., McAdam, R.A.,Hahn, J.A., Bosworth,W., Drucker, E. and Bloom, B.R. (1994) Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med., 330, 1710-1716.
42. Gurumurthy, P., Ramachandran, G., Hemanth Kumar, A.K., Rajasekaran, S., Padmapriyadarsini, C., Swaminathan, S., Bhagavathy, S., Venkatesan, P., Sekar, L., Mahilmaran, A., Ravichandran, N. and Paramesh, P. (2004) Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. Antimicrob. Agents Chemother., 48, 4473-4475.
43. Perlman, D.C., Segal, Y., Rosenkranz, S., Rainey, P.M., Remmel, R.P., Salomon, N., Hafner, R. and Peloquin, C.A. (2005) The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis. Clin. Infect. Dis., 41, 1638-1647.
44. Pinheiro, V.G., Ramos, L.M., Monteiro, H.S., Barroso, E.C., Bushen, O.Y., Facanha, M.C., Peloquin, C.A., Guerrant, R.L. and Lima, A.A. (2006) Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis. Braz. J. Infect. Dis., 10, 374-379.
45. Tappero, J.W., Bradford, W.Z., Agerton, T.B., Hopewell, P., Reingold, A.L., Lockman, S., Oyewo, A., Talbot, E.A., Kenyon, T.A., Moeti, T.L., Moffat, H.J. and Peloquin, C.A. (2005) Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin. Infect. Dis., 41, 461-469.
46. Peloquin, C.A. (1997) Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin. ChestMed., 18, 79-87.
47. Burman, W.J. and Jones, B.E. (2003) Clinical and radiographic features of HIV-related tuberculosis. Semin. Respir. Infect., 18, 263-271.
48. Di Perri, G., Cazzadori, A., Vento, S., Bonora, S., Malena, M., Bontempini, L., Lanzafame, M., Allegranzi, B. and Concia, E. (1996) Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients. Tuber. Lung Dis., 77, 244-249.
49. Keiper, M.D., Beumont, M., Elshami, A., Langlotz, C.P. and Miller, W.T. Jr, (1995) CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest, 107, 74-80.
50. Lado Lado, F.L., Barrio Gomez, E., Carballo Arceo, E. and Cabarcos Ortiz de Barron, A. (1999) Clinical presentation of tuberculosis and the degree of immunodeficiency in patients with HIV infection. Scand J. Infect. Dis., 31, 387-391.
51. Perlman, D.C., el-Sadr, W.M., Nelson, E.T.,Matts, J.P., Telzak, E.E., Salomon, N., Chirgwin, K. and Hafner, R. (1997) Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin. Infect. Dis., 25, 242-246.
52. Pozniak, A.L.,MacLeod, G.A., Ndlovu, D., Ross, E., Mahari, M. and Weinberg, J. (1995) Clinical and chest radiographic features of tuberculosis associated with human immunodeficiency virus in Zimbabwe. Am. J. Respir. Crit. Care Med., 152, 1558-1561.
53. Colebunders, R.L., Ryder, R.W., Nzilambi, N., Dikilu, K., Willame, J.C., Kaboto, M., Bagala, N., Jeugmans, J., Muepu, K. and Francis, H.L. et al. (1989) HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am. Rev. Respir. Dis., 139, 1082-1085.
54. Mugusi, F., Villamor, E., Urassa, W., Saathoff, E., Bosch, R.J. and Fawzi, W.W. (2006) HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int. J. Tuberc. Lung Dis., 10, 663-669.
55. Siddiqi, K., Lambert, M.L. and Walley, J. (2003) Clinical diagnosis of smearnegative pulmonary tuberculosis in lowincome countries: the current evidence. Lancet Infect. Dis., 3, 288-296.
56. Samb, B., Sow, P.S., Kony, S., Maynart-Badiane, M., Diouf, G., Cissokho, S., Ba, D., Sane, M., Klotz, F., Faye-Niang, M.A., Mboup, S., Ndoye, I., Delaporte, E., Hane, A.A., Samb, A., Coulaud, J.P., Coll-Seck, A.M., Larouze, B. and Murray, J.F. (1999) Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int. J. Tuberc. Lung Dis., 3, 330-336.
57. Selwyn, P.A., Hartel, D., Lewis, V.A., Schoenbaum, E.E., Vermund, S.H., Klein, R.S., Walker, A.T. and Friedland, G.H. (1989)Aprospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med., 320, 545-550.
58. Stuckler, D., Basu, S., McKee, M. and King, L. (2008) Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc. Natl Acad. Sci. USA, 105, 13280-13285.
59. Working Group of the South African Thoracic Society (2002) Management of community-acquired pneumonia in adults. S. Afr. Med. J., 92, 647-655.
60. Dooley, K.E., Golub, J., Goes, F.S., Merz, W.G. and Sterling, T.R. (2002) Empiric treatment of communityacquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin. Infect. Dis., 34, 1607-1612.
61. Gaba, P.D., Haley, C., Griffin, M.R., Mitchel, E., Warkentin, J., Holt, E., Baggett, P. and Sterling, T.R. (2007) Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease. Arch. Intern. Med., 167, 2317-2322.
62. World Health Organization (2004) Interim Policy on Collaborative TB/HIV Activities, World Health Organization, Geneva.
63. Balcells, M.E., Thomas, S.L., Godfrey-Faussett, P. and Grant, A.D. (2006) Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg. Infect. Dis., 12, 744-751.
64. Mosimaneotsile, B., Talbot, E.A., Moeti, T.L., Hone, N.M., Moalosi, G., Moffat, H.J., Lee, E.J. and Kenyon, T.A. (2003) Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet, 362, 1551-1552.
65. Day, J.H., Charalambous, S., Fielding, K.L., Hayes, R.J., Churchyard, G.J. and Grant, A.D. (2006) Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int. J. Tuberc. Lung Dis., 10, 523-529.
66. Mugisha, B., Bock, N.,Mermin, J., Odeke, R.M., Miller, B., Adatu-Engwau, F., Granich, R. and Bunnell, R. (2006) Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int. J. Tuberc. Lung Dis., 10, 761-767.
67. Cohn, M.L., Middlebrook, G. and Russell, W.F. Jr, (1959) Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J. Clin. Invest., 38, 1349-1355.
68. Billington, O.J., McHugh, T.D. and Gillespie, S.H. (1999) Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 43, 1866-1869.
69. Ordway, D.J., Sonnenberg, M.G., Donahue, S.A., Belisle, J.T. and Orme, I.M. (1995) Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect. Immun., 63, 741-743.
70. Pym, A.S., Saint-Joanis, B. and Cole, S.T. (2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun., 70, 4955-4960.
71. Hazbon, M.H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M.I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Leon, C.I., Bose, M., Chaves, F., Murray, M., Eisenach, K.D., Sifuentes-Osornio, J.,Cave, M.D., Ponce de Leon, A. and Alland, D. (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 50, 2640-2649.
72. Cohen, T., Colijn, C., Wright, A., Zignol, M., Pym, A. and Murray, M. (2008) Challenges in estimating the total burden of drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med., 177, 1302-1306.
73. Andrews, J.R., Gandhi, N.R., Moodley, P., Shah, N.S., Bohlken, L., Moll, A.P., Pillay, M., Friedland, G. and Sturm, A.W. (2008) Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J. Infect. Dis., 198, 1582-1589.
74. Murray, M. and Alland, D. (2002) Methodological problems in the molecular epidemiology of tuberculosis. Am. J. Epidemiol., 155, 565-571.
75. Garcia-Garcia, M.L., Jimenez-Corona, M.E., Ponce-de-Leon, A., Jimenez-Corona, A., Palacios-Martinez, M., Balandrano-Campos, S., Ferreyra-Reyes, L., Juarez-Sandino, L., Sifuentes-Osornio, J., Olivera-Diaz, H., Valdespino-Gomez, J.L. and Small, P.M. (2000) Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico. Int. J. Tuberc. Lung Dis., 4, S168-170.
76. Godfrey-Faussett, P., Sonnenberg, P., Shearer, S.C., Bruce, M.C., Mee, C., Morris, L. and Murray, J. (2000) Tuberculosis control and molecular epidemiology in a South African goldmining community. Lancet, 356, 1066-1071.
77. Fandinho, F.C., Kritski, A.L., Hofer, C., Junior Conde, H., Ferreira, R.M., Saad, M.H., Silva, M.G., Riley, L.W. and Fonseca, L.S. (2000) RFLP patterns and risk factors for recent tuberculosis transmission among hospitalized tuberculosis patients in Rio de Janeiro, Brazil. Trans. R. Soc. Trop. Med. Hyg., 94, 271-275.
78. Kruuner, A., Hoffner, S.E., Sillastu, H., Danilovits, M., Levina, K., Svenson, S.B., Ghebremichael, S., Koivula, T. and Kallenius, G. (2001) Spread of drug-resistant pulmonary tuberculosis in Estonia. J. Clin. Microbiol., 39, 3339-3345.
79. Toungoussova, O.S., Sandven, P., Mariandyshev, A.O., Nizovtseva, N.I., Bjune, G. and Caugant, D.A. (2002) Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol., 40, 1930-1937.
80. Basu, S., Andrews, J.R., Poolman, E.M., Gandhi, N.R., Shah, N.S., Moll, A., Moodley, P., Galvani, A.P. and Friedland, G.H. (2007) Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet, 370, 1500-1507.
81. Horsburgh, C.R. Jr, (2008) Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons: what does the future hold in store? J. Infect. Dis., 198, 1577-1578.
82. Li, X., Zhang, Y., Shen, X., Shen, G., Gui, X., Sun, B., Mei, J., Deriemer, K., Small, P.M. and Gao, Q. (2007) Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J. Infect. Dis., 195, 864-869.
83. Cruciani, M., Malena, M., Bosco, O., Gatti, G. and Serpelloni, G. (2001) The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin. Infect. Dis., 33, 1922-1930.
84. Escombe, A.R., Moore, D.A., Gilman, R.H., Pan, W., Navincopa, M., Ticona, E., Martinez, C., Caviedes, L., Sheen, P., Gonzalez, A., Noakes, C.J., Friedland, J.S. and Evans, C.A. (2008) The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med., 5, e188.
85. Gilks, C.F., Floyd, K., Otieno, L.S., Adam, A.M., Bhatt, S.M. and Warrell, D.A. (1998) Some effects of the rising case load of adult HIV-related disease on a hospital in Nairobi. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 18, 234-240.
86. Arthur, G., Bhatt, S.M., Muhindi, D., Achiya, G.A., Kariuki, S.M. and Gilks, C.F. (2000) The changing impact of HIV/AIDS onKenyatta National Hospital, Nairobi from 1988/89 through 1992 to 1997. AIDS, 14, 1625-1631.
87. Getahun, H.,Harrington, M., O'Brien, R. and Nunn, P. (2007) Diagnosis of smearnegative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet, 369, 2042-2049.
88. Blower, S.M. and Chou, T. (2004) Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat. Med., 10, 1111-1116.
89. Pai, M., Ramsay,A. and O'Brien, R. (2008) Evidence-based tuberculosis diagnosis. PLoS Med., 5, e156.
90. Palomino, J.C., Martin, A., Von Groll, A. and Portaels, F. (2008) Rapid culturebased methods for drug-resistance detection in Mycobacterium tuberculosis. J. Microbiol. Methods, 75, 161-166.
91. Moore, D.A., Evans, C.A., Gilman, R.H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Pinedo, Y., Saravia, J.C., Salazar, C., Oberhelman, R., Hollm-Delgado, M.G., LaChira, D., Escombe, A.R. and Friedland, J.S. (2006) Microscopic-observation drugsusceptibility assay for the diagnosis of TB. N. Engl. J. Med., 355, 1539-1550.
92. Kivihya-Ndugga, L.E., van Cleeff, M.R., Githui,W.A., Nganga, L.W., Kibuga, D.K., Odhiambo, J.A. and Klatser, P.R. (2003) A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int. J. Tuberc. Lung Dis., 7, 1163-1171.
93. Steingart, K.R., Henry, M., Ng, V., Hopewell, P.C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M., Aziz, M.A. and Pai, M. (2006) Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis., 6, 570-581.
94. Prasanthi, K. and Kumari, A.R. (2005) Efficacy of fluorochrome stain in the diagnosis of pulmonary tuberculosis co-infected with HIV. Indian J. Med. Microbiol., 23, 179-181.
95. Drobniewski, F.A., Caws, M., Gibson, A. and Young, D. (2003) Modern laboratory diagnosis of tuberculosis. Lancet Infect. Dis., 3, 141-147.
96. Pai, M., Kalantri, S., Pascopella, L., Riley, L.W. and Reingold, A.L. (2005) Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a metaanalysis. J. Infect., 51, 175-187.
97. Ling, D.I., Zwerling, A.A. and Pai, M. (2008) GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J., 32, 1165-1174.
98. Boehme, C., Molokova, E., Minja, F., Geis, S., Loscher, T., Maboko, L., Koulchin, V. and Hoelscher, M. (2005) Detection of mycobacterial lipoarabinomannan with an antigencapture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R. Soc. Trop. Med. Hyg., 99, 893-900.
99. Wilson, D., Nachega, J., Morroni, C., Chaisson, R. and Maartens, G. (2006) Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int. J. Tuberc. Lung Dis., 10, 31-38.
100. Epstein, M.D., Schluger, N.W., Davidow, A.L., Bonk, S., Rom, W.N. and Hanna, B. (1998) Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest, 113, 379-386.
101. Banerjee, R., Allen, J., Westenhouse, J., Oh, P., Elms, W., Desmond, E., Nitta, A., Royce, S. and Flood, J. (2008) Extensively drug-resistant tuberculosis in California, 1993-2006. Clin. Infect. Dis., 47, 450-457.
102. Jeon, C.Y., Hwang, S.H., Min, J.H., Prevots, D.R., Goldfeder, L.C., Lee, H., Eum, S.Y., Jeon, D.S., Kang, H.S., Kim, J.H., Kim, B.J., Kim, D.Y., Holland, S.M., Park, S.K., Cho, S.N., Barry, C.E. 3rd, and Via, L.E. (2008) Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin. Infect. Dis., 46, 42-49.
103. Keshavjee, S., Gelmanova, I.Y., Farmer, P.E., Mishustin, S.P., Strelis, A.K., Andreev, Y.G., Pasechnikov, A.D., Atwood, S., Mukherjee, J.S., Rich, M.L., Furin, J.J., Nardell, E.A., Kim, J.Y. and Shin, S.S. (2008) Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet, 372, 1403-1409.
104. Kim, D.H., Kim, H.J., Park, S.K., Kong, S.J., Kim, Y.S., Kim, T.H., Kim, E.K., Lee, K.M., Lee, S.S., Park, J.S., Koh, W.J., Lee, C.H., Kim, J.Y. and Shim, T.S. (2008) Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med., 178, 1075-1082.
105. Kwon, Y.S., Kim, Y.H., Suh, G.Y., Chung, M.P., Kim, H., Kwon, O.J., Choi, Y.S., Kim, K., Kim, J., Shim, Y.M. and Koh,W.J. (2008) Treatment outcomes for HIV-uninfected patients with multidrugresistant and extensively drug-resistant tuberculosis. Clin. Infect. Dis., 47, 496-502.
106. Mitnick, C.D., Shin, S.S., Seung, K.J., Rich, M.L., Atwood, S.S., Furin, J.J., Fitzmaurice, G.M., Alcantara Viru, F.A., Appleton, S.C., Bayona, J.N., Bonilla, C.A., Chalco, K., Choi, S., Franke, M.F., Fraser, H.S., Guerra, D., Hurtado, R.M., Jazayeri, D., Joseph, K., Llaro, K., Mestanza, L.,Mukherjee, J.S.,Munoz, M., Palacios, E., Sanchez, E., Sloutsky, A. and Becerra, M.C. (2008) Comprehensive treatment of extensively drug-resistant tuberculosis. N. Engl. J. Med., 359, 563-574.
107. Cox, H. and McDermid, C. (2008) XDR tuberculosis can be cured with aggressive treatment. Lancet, 372, 1363-1365.
108. Singh, S., Sankar, M.M. and Gopinath, K. (2007) High rate of extensively drugresistant tuberculosis in Indian AIDS patients. AIDS, 21, 2345-2347.
109. Madariaga, M.G., Lalloo, U.G. and Swindells, S. (2008) Extensively drugresistant tuberculosis. Am. J. Med., 121, 835-844.
110. Mukherjee, J.S., Rich, M.L., Socci, A.R., Joseph, J.K., Viru, F.A., Shin, S.S., Furin, J.J., Becerra, M.C., Barry, D.J., Kim, J.Y., Bayona, J., Farmer, P., Smith Fawzi, M.C. and Seung, K.J. (2004) Programmes and principles in treatment of multidrugresistant tuberculosis. Lancet, 363, 474-481.